Kurup V P, Resnick A, Kalbfleish J, Fink J N
Research Service, Zablocki Veterans Affairs Medical Center, Milwaukee, WI.
J Lab Clin Med. 1990 Mar;115(3):298-303.
The Aspergillus fumigatus-specific immunoglobulin class and subclasses were evaluated in the sera of patients with allergic bronchopulmonary aspergillosis, aspergilloma, patients with asthma and immediate wheal-and-flare skin test reactivity to Aspergillus antigens, and normal controls. A sensitive sandwich enzyme immunoassay using a biotin-avidin amplification system was used to detect the specific antibodies. No difference was demonstrated in the specific antibody levels against A. fumigatus between the normal controls and A. fumigatus skin test-reactive asthmatic subjects except for immunoglobulin IgD and IgG4 isotypes. Allergic bronchopulmonary aspergillosis (ABPA) sera showed significant elevation of A. fumigatus-specific antibodies of all isotypes. On the other hand, aspergilloma sera, when compared with that of asthmatic individuals, showed significant increases of IgA, IgG1, IgG2, and IgG3 antibodies. The specific antibodies belonging to both IgG1 and IgG2 subclasses were elevated in ABPA, the former predominant in 40% of cases and the latter in 60%, while in aspergilloma IgG1 was predominant. Among the initially diagnosed ABPA patients, all specific Ig isotypes were considerably elevated when compared with sera from other patients being treated with prednisone or when compared with sera from patients who became asymptomatic after treatment.
对变应性支气管肺曲霉病、曲菌球患者、对曲霉抗原即刻风团和潮红皮肤试验有反应的哮喘患者以及正常对照者的血清中烟曲霉特异性免疫球蛋白类别和亚类进行了评估。使用生物素-抗生物素蛋白放大系统的灵敏夹心酶免疫测定法来检测特异性抗体。除免疫球蛋白IgD和IgG4同种型外,正常对照者与对烟曲霉皮肤试验有反应的哮喘受试者之间,针对烟曲霉的特异性抗体水平未显示出差异。变应性支气管肺曲霉病(ABPA)血清显示所有同种型的烟曲霉特异性抗体均显著升高。另一方面,与哮喘患者相比,曲菌球血清中IgA、IgG1、IgG2和IgG3抗体显著增加。ABPA中属于IgG1和IgG2亚类的特异性抗体均升高,前者在40%的病例中占主导,后者在60%的病例中占主导,而在曲菌球中IgG1占主导。在最初诊断的ABPA患者中,与接受泼尼松治疗的其他患者的血清相比,或与治疗后无症状患者的血清相比,所有特异性Ig同种型均显著升高。